The α1-adrenergic receptors: Diversity of signaling networks and regulation

Journal of Receptors and Signal Transduction

Volumn 30, Issue 6, 2010, Pages 410-419

  Cotecchia, Susanna ^a,b  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

arrestin; Constitutive activity; knock out mice; oligomerization; protein interactions; transgenic mice

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; RECEPTOR SUBTYPE;

DNA MODIFICATION; HUMAN; NONHUMAN; OLIGOMERIZATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ARRESTINS; EPINEPHRINE; NOREPINEPHRINE; PROTEIN ISOFORMS; RECEPTORS, ADRENERGIC, ALPHA-1; SIGNAL TRANSDUCTION;

MUS; MUS MUSCULUS;

EID: 78649662125     PISSN: 10799893     EISSN: 15324281     Source Type: Journal    
DOI: 10.3109/10799893.2010.518152     Document Type: Review

References (57)

1. Graham RM, Perez DM, Hwa J, Piascik MT. alpha 1-adrenergic receptor subtypes. Molecular structure, function, and signaling. Circ Res 1996, 78, 737-749.
2. Michel MC, Kenny B, Schwinn DA. Classifcation of alpha 1-adrenoceptor subtypes. Naunyn Schmiedebergs Arch Pharmacol 1995, 352, 1-10.
3. Schwinn DA, Johnston GI, Page SO, Mosley MJ, Wilson KH, Worman NP, Campbell S, Fidock MD, Furness LM, Parry-Smith DJ. Cloning and pharmacological characterization of human alpha-1 adrenergic receptors: sequence corrections and direct comparison with other species homologues. J Pharmacol Exp Ter 1995, 272, 134-142.
4. Cotecchia S, Stanasila L, Diviani D, Björklöf K, Rossier O, Fanelli F. Structural determinants involved in the activation and regulation of G protein-coupled receptors: lessons from the alpha1-adrenegic receptor subtypes. Biol Cell 2004, 96, 327-333.
5. Cotecchia S, Björklöf K, Rossier O, Stanasila L, Greasley P, Fanelli F. Te alpha1b-adrenergic receptor subtype: molecular properties and physiological implications. J Recept Signal Transduct Res 2002, 22, 1-16.
6. Costa T, Cotecchia S. Historical review: Negative efcacy and the constitutive activity of G-protein-coupled receptors. Trends Pharmacol Sci 2005, 26, 618-624.
7. Angers S, Salahpour A, Bouvier M. Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. Annu Rev Pharmacol Toxicol 2002, 42, 409-435.
8. Ritter SL, Hall RA. Fine-tuning of GPCR activity by receptor-interacting proteins. Nat Rev Mol Cell Biol 2009, 10, 819-830.
9. Kjelsberg MA, Cotecchia S, Ostrowski J, Caron MG, Lefkowitz RJ. Constitutive activation of the alpha 1B-adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation. J Biol Chem 1992, 267, 1430-1433.
10. Rossier O, Abuin L, Fanelli F, Leonardi A, Cotecchia S. Inverse agonism and neutral antagonism at alpha(1a)-and alpha(1b)-adrenergic receptor subtypes. Mol Pharmacol 1999, 56, 858-866.
11. Scheer A, Fanelli F, Costa T, De Benedetti PG, Cotecchia S. Te activation process of the alpha1B-adrenergic receptor: potential role of protonation and hydrophobicity of a highly conserved aspartate. Proc Natl Acad Sci USA 1997, 94, 808-813.
12. Greasley PJ, Fanelli F, Rossier O, Abuin L, Cotecchia S. Mutagenesis and modelling of the alpha(1b)-adrenergic receptor highlight the role of the helix 3/helix 6 interface in receptor activation. Mol Pharmacol 2002, 61, 1025-1032.
13. Teroux TL, Esbenshade TA, Peavy RD, Minneman KP. Coupling efciencies of human alpha 1-adrenergic receptor subtypes: titration of receptor density and responsiveness with inducible and repressible expression vectors. Mol Pharmacol 1996, 50, 1376-1387.
14. McWhinney C, Wenham D, Kanwal S, Kalman V, Hansen C, Robishaw JD. Constitutively active mutants and the alpha(1b)-adrenergic receptor subtypes reveal coupling to diferent signaling pathways and physiological responses in rat cardiac myocytes. J Biol Chem 2000, 275, 2087-2097.
15. Hague C, Uberti MA, Chen Z, Hall RA, Minneman KP. Cell surface expression of alpha1D-adrenergic receptors is controlled by het-erodimerization with alpha1B-adrenergic receptors. J Biol Chem 2004, 279, 15541-15549.
16. Uberti MA, Hague C, Oller H, Minneman KP, Hall RA. Heterodimerization with beta2-adrenergic receptors promotes surface expression and functional activity of alpha1D-adrenergic receptors. J Pharmacol Exp Ter 2005, 313, 16-23.
17. García-Sáinz JA, Torres-Padilla ME. Modulation of basal intracel-lular calcium by inverse agonists and phorbol myristate acetate in rat-1 fbroblasts stably expressing alpha1d-adrenoceptors. FEBS Lett 1999, 443, 277-281.
18. Gisbert R, Ziani K, Miquel R, Noguera MA, Ivorra MD, Anselmi E, D'Ocon P. Pathological role of a constitutively active population of alpha(1D)- adrenoceptors in arteries of spontaneously hypertensive rats. Br J Pharmacol 2002, 135, 206-216.
19. Stanasila L, Perez JB, Vogel H, Cotecchia S. Oligomerization of the alpha 1a-and alpha 1b-adrenergic receptor subtypes. Potential implications in receptor internalization. J Biol Chem 2003, 278, 40239-40251.
20. Perez DM, DeYoung MB, Graham RM. Coupling of expressed alpha 1B-and alpha 1D-adrenergic receptor to multiple signaling pathways is both G protein and cell type specifc. Mol Pharmacol 1993, 44, 784-795.
21. Hu ZW, Shi XY, Lin RZ, Hofman BB. Contrasting signaling pathways of alpha1A-and alpha1B-adrenergic receptor subtype activation of phosphatidylinositol 3-kinase and Ras in transfected NIH3T3 cells. Mol Endocrinol 1999, 13, 3-14.
22. Nguyen VA, Gao B. Cross-talk between alpha(1B)-adrenergic receptor (alpha(1B)AR) and interleukin-6 (IL-6) signaling pathways. Activation of alpha(1b)AR inhibits il-6-activated STAT3 in hepatic cells by a p42/44 mitogen-activated protein kinase-dependent mechanism. J Biol Chem 1999, 274, 35492-35498.
23. Gonzalez-Cabrera PJ, Shi T, Yun J, McCune DF, Rorabaugh BR, Perez DM. Diferential regulation of the cell cycle by alpha1-adrenergic receptor subtypes. Endocrinology 2004, 145, 5157-5167.
24. Iwaki K, Sukhatme VP, Shubeita HE, Chien KR. Alpha-and beta-adrenergic stimulation induces distinct patterns of immediate early gene expression in neonatal rat myocardial cells. fos/jun expression is associated with sarcomere assembly; Egr-1 induction is primarily an alpha 1-mediated response. J Biol Chem 1990, 265, 13809-13817.
25. Knowlton KU, Michel MC, Itani M, Shubeita HE, Ishihara K, Brown JH, Chien KR. Te alpha 1A-adrenergic receptor subtype mediates biochemical, molecular, and morphologic features of cultured myocardial cell hypertrophy. J Biol Chem 1993, 268, 15374-15380.
26. Ramirez MT, Sah VP, Zhao XL, Hunter JJ, Chien KR, Brown JH. Te MEKK-JNK pathway is stimulated by alpha1-adren-ergic receptor and ras activation and is associated with in vitro and in vivo cardiac hypertrophy. J Biol Chem 1997, 272, 14057-14061.
27. Sah VP, Hoshijima M, Chien KR, Brown JH. Rho is required for Galphaq and alpha1-adrenergic receptor signaling in cardiomyo-cytes. Dissociation of Ras and Rho pathways. J Biol Chem 1996, 271, 31185-31190.
28. Maruyama Y, Nishida M, Sugimoto Y, Tanabe S, Turner JH, Kozasa T, Wada T, Nagao T, Kurose H. Galpha(12/13) mediates alpha(1)-adrenergic receptor-induced cardiac hypertrophy. Circ Res 2002, 91, 961-969.
29. Appert-Collin A, Cotecchia S, Nenniger-Tosato M, Pedrazzini T, Diviani D. Te A-kinase anchoring protein (AKAP)-Lbc-signaling complex mediates alpha1 adrenergic receptor-induced car-diomyocyte hypertrophy. Proc Natl Acad Sci USA 2007, 104, 10140-10145.
30. Diviani D, Lattion AL, Larbi N, Kunapuli P, Pronin A, Benovic JL, Cotecchia S. Effect of different G protein-coupled receptor kinases on phosphorylation and desensitization of the alpha1B-adrenergic receptor. J Biol Chem 1996, 271, 5049-5058.
31. Diviani D, Lattion AL, Cotecchia S. Characterization of the phospho-rylation sites involved in G protein-coupled receptor kinase-and protein kinase C-mediated desensitization of the alpha1B-adren-ergic receptor. J Biol Chem 1997, 272, 28712-28719.
32. Stanasila L, Abuin L, Dey J, Cotecchia S. Diferent internaliza-tion properties of the alpha1a-and alpha1b-adrenergic receptor subtypes: the potential role of receptor interaction with beta-arrestins and AP50. Mol Pharmacol 2008, 74, 562-573.
33. Vázquez-Prado J, Medina LC, Romero-Avila MT, González- Espinosa C, García-Sáinz JA. Norepinephrine-and phorbol ester-induced phosphorylation of alpha(1a)-adrenergic receptors. Functional aspects. J Biol Chem 2000, 275, 6553-6559.
34. García-Sáinz JA, Rodríguez-Pérez CE, Romero-Avila MT. Human alpha1D-adrenoceptor phosphorylation and desensitization. Biochem Pharmacol 2004, 67, 1853-1858.
35. De Wire SM, Seungkirl A, Lefkowitz RJ, Shenoy SK. Beta-arrestins and cell signaling. Annu Rev Physiol 2007, 69, 483-510.
36. Pupo AS, Minneman KP. Interaction of neuronal nitric oxide synthase with alpha1-adrenergic receptor subtypes in transfected HEK-293 cells. BMC Pharmacol 2002, 2, 17.
37. Xu Q, Xu N, Zhang T, Zhang H, Li Z, Yin F, Lu Z, Han Q, Zhang Y. Mammalian tolloid alters subcellular localization, internalization, and signaling of alpha(1a)-adrenergic receptors. Mol Pharmacol 2006, 70, 532-541.
38. Hague C, Bernstein LS, Ramineni S, Chen Z, Minneman KP, Hepler JR. Selective inhibition of alpha1A-adrenergic receptor signaling by RGS2 association with the receptor third intracel-lular loop. J Biol Chem 2005, 280, 27289-27295.
39. Bernstein LS, Ramineni S, Hague C, Cladman W, Chidiac P, Levey AI, Hepler JR. RGS2 binds directly and selectively to the M1 muscarinic acetylcholine receptor third intracellular loop to modulate Gq/11alpha signaling. J Biol Chem 2004, 279, 21248-21256.
40. Diviani D, Lattion AL, Abuin L, Staub O, Cotecchia S. Te adaptor complex 2 directly interacts with the alpha 1b-adrenergic receptor and plays a role in receptor endocytosis. J Biol Chem 2003, 278, 19331-19340.
41. Stanasila L, Abuin L, Diviani D, Cotecchia S. Direct interaction of ezrin with the alpha1b-adrenergic receptor regulates recycling of the internalized receptors. J Biol Chem 2006, 281, 4354-4363.
42. Pupo AS, Minneman KP. Specifc interactions between gC1qR and alpha1-adrenoceptor subtypes. J Recept Signal Transduct Res 2003, 23, 185-195.
43. Wang Q, Zhao J, Brady AE, Feng J, Allen PB, Lefkowitz RJ, Greengard P, Limbird LE. Spinophilin blocks arrestin actions in vitro and in vivo at G protein-coupled receptors. Science 2004, 304, 1940-1944.
44. Chen Z, Hague C, Hall RA, Minneman KP. Syntrophins regulate alpha1D-adrenergic receptors through a PDZ domain-mediated interaction. J Biol Chem 2006, 281, 12414-12420.
45. Cavalli A, Lattion AL, Hummler E, Nenniger M, Pedrazzini T, Aubert JF, Michel MC, Yang M, Lembo G, Vecchione C, Mostardini M, Schmidt A, Beermann F, Cotecchia S. Decreased blood pressure response in mice defcient of the alpha1b-adren-ergic receptor. Proc Natl Acad Sci USA 1997, 94, 11589-11594.
46. Burcelin R, Uldry M, Foretz M, Perrin C, Dacosta A, Nenniger-Tosato M, Seydoux J, Cotecchia S, Torens B. Impaired glucose homeostasis in mice lacking the alpha1b-adrenergic receptor subtype. J Biol Chem 2004, 279, 1108-1115.
47. Auclair A, Drouin C, Cotecchia S, Glowinski J, Tassin JP. 5-HT2A and alpha1b-adrenergic receptors entirely mediate dopamine release, locomotor response and behavioural sensitization to opiates and psychostimulants. Eur J Neurosci 2004, 20, 3073-3084.
48. Rokosh DG, Simpson PC. Knockout of the alpha 1A/C-adrenergic receptor subtype: the alpha 1A/C is expressed in resistance arteries and is required to maintain arterial blood pressure. Proc Natl Acad Sci USA 2002, 99, 9474-9479.
49. Tanoue A, Nasa Y, Koshimizu T, Shinoura H, Oshikawa S, Kawai T, Sunada S, Takeo S, Tsujimoto G. Te alpha(1D)-adrenergic receptor directly regulates arterial blood pressure via vasoconstriction. J Clin Invest 2002, 109, 765-775.
50. Milano CA, Dolber PC, Rockman HA, Bond RA, Venable ME, Allen LF, Lefkowitz RJ. Myocardial expression of a constitutively active alpha 1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy. Proc Natl Acad Sci USA 1994, 91, 10109-10113.
51. Dorn GW 2nd, Brown JH. Gq signaling in cardiac adaptation and maladaptation. Trends Cardiovasc Med 1999, 9, 26-34.
52. Zuscik MJ, Chalothorn D, Hellard D, Deighan C, McGee A, Daly CJ, Waugh DJ, Ross SA, Gaivin RJ, Morehead AJ, Tomas JD, Plow EF, McGrath JC, Piascik MT, Perez DM. Hypotension, auto-nomic failure, and cardiac hypertrophy in transgenic mice over-expressing the alpha 1B-adrenergic receptor. J Biol Chem 2001, 276, 13738-13743.
53. O'Connell TD, Ishizaka S, Nakamura A, Swigart PM, Rodrigo MC, Simpson GL, Cotecchia S, Rokosh DG, Grossman W, Foster E, Simpson PC. Te alpha(1A/C)-and alpha(1B)-adrenergic receptors are required for physiological cardiac hypertrophy in the double-knockout mouse. J Clin Invest 2003, 111, 1783-1791.
54. Lin F, Owens WA, Chen S, Stevens ME, Kesteven S, Arthur JF, Woodcock EA, Feneley MP, Graham RM. Targeted alpha(1A)-adrenergic receptor overexpression induces enhanced cardiac contractility but not hypertrophy. Circ Res 2001, 89, 343-350.
55. Akhter SA, Milano CA, Shotwell KF, Cho MC, Rockman HA, Lefkowitz RJ, Koch WJ. Transgenic mice with cardiac overexpres-sion of alpha1B-adrenergic receptors. In vivo alpha1-adrenergic receptor-mediated regulation of beta-adrenergic signaling. J Biol Chem 1997, 272, 21253-21259.
56. Woodcock EA. Roles of α1A and α1B-adrenoceptors in heart: insights from studies on genetically modifed mice. Clin and Exp Pharmacol and Physiol 2007 34, 884-888.
57. Hosoda C, Koshimizu TA, Tanoue A, Nasa Y, Oikawa R, Tomabechi T, Fukuda S, Shinoura H, Oshikawa S, Takeo S, Kitamura T, Cotecchia S, Tsujimoto G. Two alpha1-adrenergic receptor subtypes regulating the vasopressor response have differential roles in blood pressure regulation. Mol Pharmacol 2005, 67, 912-922.